Showing results (121-130 of 212) with videos related to

Sort By:
Pageof 22
Scientific Reports|February 13, 2023
Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in KoreaDa Jung Kim, Seri Jeong, Seom Gim Kong, et al.
European Journal of Haematology|August 19, 2007
Intestinal marginal zone B-cell lymphoma of MALT type: clinical manifestation and outcome of a rare diseaseSung Yong Oh, Hyuk-Chan Kwon, Won Seog Kim, et al.
Cancers|July 27, 2022
Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint InhibitorsHye Ryeon Kim, Jung Hun Kang, Sung Hyun Kim, et al.
The Korean Journal of Internal Medicine|March 13, 2016
Clinicopathologic significance of tumor microenvironment CD11c, and FOXP3 expression in diffuse large B-cell lymphoma patients receiving rituximab, cyclophosphamide, anthracycline, vincristine, and prednisone (R-CHOP) combination chemotherapySeul Lee, Dong Hyun Kim, Sung Yong Oh, et al.
Annals of Hematology|August 24, 2017
Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scoresHyewon Lee, Yu Ri Kim, Soo-Jeong Kim, et al.
British Journal of Haematology|November 20, 2020
A prognostic index for extranodal marginal-zone lymphoma based on the mucosa-associated lymphoid tissue International Prognostic Index and serum β2-microglobulin levelsHyung-Don Kim, Hyungwoo Cho, Hyehyun Jeong, et al.
BMC Cancer|May 22, 2009
Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancerDo-Kyong Kim, Sung Yong Oh, Hyuk-Chan Kwon, et al.
BMC Cancer|May 15, 2010
Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancerKyung A Kwon, Sung Hyun Kim, Sung Yong Oh, et al.
International Journal of Hematology|June 29, 2019
The Glasgow Prognostic Score is a significant predictor of peripheral T-cell lymphoma (PTCL) treated with CHOP-based chemotherapy and comparable with PTCL prognostic scoresSeok Jae Huh, Sung Yong Oh, Suee Lee, et al.
British Journal of Haematology|March 13, 2014
A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphomaMichinori Ogura, Kiyoshi Ando, Tatsuya Suzuki, et al.
Pageof 22